Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity

Table 3 Multiple comparisons of gene expression of Tregs markers in the four studied groups

	Group I naïve	Group II Peg/Riba	Group III ANA+	Group IV control
FOX3
Group I naïve		aP ≤ 0.05	dP ≤ 0.001	bP ≤ 0.01
Group II Peg/Riba	aP ≤ 0.05		aP ≤ 0.05	bP ≤ 0.01
Group III ANA+	dP ≤ 0.001	aP ≤ 0.05		dP ≤ 0.001
Group IV control	bP ≤ 0.01	bP ≤ 0.01	dP ≤ 0.001
CD69
Group I naïve		bP ≤ 0.01	bP ≤ 0.01	dP ≤ 0.001
Group II Peg/Riba	bP ≤ 0.01		bP ≤ 0.01	dP ≤ 0.001
Group III ANA+	bP ≤ 0.01	bP ≤ 0.01		dP ≤ 0.001
Group IV control	dP ≤ 0.001	dP ≤ 0.001	dP ≤ 0.001
Granzyme
Group I naïve		dP ≤ 0.001	dP ≤ 0.001	dP ≤ 0.001
Group II Peg/Riba	dP ≤ 0.001		bP ≤ 0.01	dP ≤ 0.001
Group III ANA+	dP ≤ 0.001	bP ≤ 0.01		dP ≤ 0.001
Group IV control	dP ≤ 0.001	dP ≤ 0.001	dP ≤ 0.001

ANA: Antinuclear antibody.